Cargando…
Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Anti-programmed cell death 1 (PD-1) or anti-PD-ligand (L) 1 drugs, as classic immune checkpoint inhibitors, are considered promising treatment strategies for tumors. In clinical practice, some cancer patients experience drug resistance and disease progression in the process of anti-PD-1/PD-L1 immuno...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110638/ https://www.ncbi.nlm.nih.gov/pubmed/35592338 http://dx.doi.org/10.3389/fimmu.2022.874589 |